Association of Plasma Homocysteine in Elderly Persons with Atherosclerotic Vascular Disease and Dementia, Atherosclerotic Vascular Disease Without Dementia, Dementia Without Atherosclerotic Vascular Disease, and No Dementia or Atherosclerotic Vascular Disease

Samantha G. Storey, Vana Suryadevara, Wilbert S. Aronow, Chul Ahn

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Background. Increased plasma homocysteine has been associated with atherosclerotic vascular disease in elderly persons. The Framingham Study found that plasma homocysteine was a risk factor for dementia and Alzheimer's disease. Methods. We investigated in an academic nursing home the association of plasma homocysteine with atherosclerotic vascular disease plus dementia (group 1), atherosclerotic vascular disease without dementia (group 2), dementia without atherosclerotic vascular disease (group 3), and no dementia or atherosclerotic vascular disease (group 4). Results. The mean plasma homocysteine level was 15. 3 ± 3.0 μmol/L in 50 group 1 patients, 15.1 ± 2.7 μmol/L in 50 group 2 patients, 14.4 ± 2.7 μmol/L in 50 group 3 patients, and 10.6 ± 3.2 μmol/L in 50 group 4 patients (p < .0001 for group 1 vs group 4, for group 2 vs group 4, and for group 3 vs group 4). Conclusions. The mean plasma homocysteine level was significantly higher in elderly patients with atherosclerotic vascular disease plus dementia, atherosclerotic vascular disease without dementia, and dementia without atherosclerotic vascular disease than in patients with no dementia or atherosclerotic vascular disease.

Original languageEnglish (US)
Pages (from-to)1135-1136
Number of pages2
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume58
Issue number12
StatePublished - Dec 1 2003

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Association of Plasma Homocysteine in Elderly Persons with Atherosclerotic Vascular Disease and Dementia, Atherosclerotic Vascular Disease Without Dementia, Dementia Without Atherosclerotic Vascular Disease, and No Dementia or Atherosclerotic Vascular Disease'. Together they form a unique fingerprint.

Cite this